Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP300873.RAQPAD3zazPWxudh9TsxAU1dlR1trN7rGHmtPUDYN_U6Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP300873.RAQPAD3zazPWxudh9TsxAU1dlR1trN7rGHmtPUDYN_U6Y130_assertion type Assertion NP300873.RAQPAD3zazPWxudh9TsxAU1dlR1trN7rGHmtPUDYN_U6Y130_head.
- NP300873.RAQPAD3zazPWxudh9TsxAU1dlR1trN7rGHmtPUDYN_U6Y130_assertion description "[Loss of heterozygosity studies in melanoma and pancreatic carcinoma from gene carriers strongly support the view that CDKN2 is a general tumour suppressor gene predisposing not only to melanoma but also to other malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300873.RAQPAD3zazPWxudh9TsxAU1dlR1trN7rGHmtPUDYN_U6Y130_provenance.
- NP300873.RAQPAD3zazPWxudh9TsxAU1dlR1trN7rGHmtPUDYN_U6Y130_assertion evidence source_evidence_literature NP300873.RAQPAD3zazPWxudh9TsxAU1dlR1trN7rGHmtPUDYN_U6Y130_provenance.
- NP300873.RAQPAD3zazPWxudh9TsxAU1dlR1trN7rGHmtPUDYN_U6Y130_assertion SIO_000772 7640518 NP300873.RAQPAD3zazPWxudh9TsxAU1dlR1trN7rGHmtPUDYN_U6Y130_provenance.
- NP300873.RAQPAD3zazPWxudh9TsxAU1dlR1trN7rGHmtPUDYN_U6Y130_assertion wasDerivedFrom befree-20150227 NP300873.RAQPAD3zazPWxudh9TsxAU1dlR1trN7rGHmtPUDYN_U6Y130_provenance.
- NP300873.RAQPAD3zazPWxudh9TsxAU1dlR1trN7rGHmtPUDYN_U6Y130_assertion wasGeneratedBy ECO_0000203 NP300873.RAQPAD3zazPWxudh9TsxAU1dlR1trN7rGHmtPUDYN_U6Y130_provenance.